Trials that use: P-values
New to this method? Read the tutorial →
20,601 results
- NKTR-102 in Combination With Cetuximab in Patients With Refractory Solid Tumors (Phase 2a) and Metastatic or Locally Advanced Colorectal Cancer (Phase 2b): Complete Statistical AnalysisIndependent statistical analysis of NKTR-102 in Combination With Cetuximab in Patients With Refractory Solid Tumors (Phase 2a) and Metastatic or Locally Advanced Colorectal Cancer (Phase 2b): primary endpoint results, effect estimate with…
- NKTR-214Independent statistical analysis of A Phase 1/2 Multicenter Dose Escalation and Expansion Study Of NKTR-214 In Subjects With Locally Advanced Or Metastatic Solid Tumors: primary endpoint results, effect estimate with confidence interval,…
- NMDA Antagonists in Bipolar Depression: Complete Statistical AnalysisIndependent statistical analysis of NMDA Antagonists in Bipolar Depression: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01833897).
- NMDA Receptors in Motor Learning in Humans: Complete Statistical AnalysisIndependent statistical analysis of NMDA Receptors in Motor Learning in Humans: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02082912).
- NMES Efficacy on Patients With NBPP: Complete Statistical AnalysisIndependent statistical analysis of NMES Efficacy on Patients With NBPP: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01999465).
- NMES for Achilles Tendon Rupture: Complete Statistical AnalysisIndependent statistical analysis of NMES for Achilles Tendon Rupture: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04727047).
- No Drop Post-Op Cataract Surgery: Complete Statistical AnalysisIndependent statistical analysis of No Drop Post-Op Cataract Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03864133).
- No ShowIndependent statistical analysis of Using Behavioral Economics to Enhance Appointment Reminders and Reduce Missed Visits: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- NO-ASPIRATEIndependent statistical analysis of Oral Suction Intervention to Reduce Aspiration and Ventilator Events: NO-ASPIRATE: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02284178).
- NO-COVID-19Independent statistical analysis of Inhaled Nitric Oxide for Preventing Progression in COVID-19: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04388683).
- no-cryIndependent statistical analysis of Preliminary Efficacy and Safety Study of Oral Nepadutant in Infant Colic: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- No-POPPYIndependent statistical analysis of Non-Opiate Treatment After Prenatal Opiate Exposure to Prevent Postnatal Injury to the Young Brain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- NO-UTIIndependent statistical analysis of Short-course Methenamine Hippurate for Prevention of Post-operative UTI: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02358993).
- NO16968Independent statistical analysis of NO16968 (NCT00069121), a randomized phase 3 trial of capecitabine plus oxaliplatin versus 5-FU/LV in colorectal cancer, including disease-free survival, relapse-free survival, overall survival, statistical methodology, and interpretation.
- NOAHComplete statistical analysis of the NOAH phase 3 trial of edoxaban versus ASA or placebo in patients with atrial high rate episodes, including trial design, time-to-event methodology, primary and secondary results, safety,…
- NOAHIndependent statistical analysis of Non-vitamin K Antagonist Oral Anticoagulants in Patients With Atrial High Rate Episodes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Nociceptors, Neurotrophic Factors and Cytokine Expression in Gastroesophageal Reflux Disease: Complete Statistical AnalysisIndependent statistical analysis of Nociceptors, Neurotrophic Factors and Cytokine Expression in Gastroesophageal Reflux Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02114216).
- NOCTIndependent statistical analysis of Multicenter Randomized Parallel Group Phase III Study Comparing the Bowel Cleansing Efficacy, Safety and Tolerability of NER1006 Versus Trisulfate Solution Using 2-Day Split-Dosing Regimen in Adults: primary endpoint…
- NOCTETIndependent statistical analysis of Nordic Everolimus (Certican) Trial in Heart and Lung Transplantation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00377962).
- NOCTURNEIndependent statistical analysis of 8-Week Study of Tolvaptan Dose Forms in Autosomal Dominant Polycystic Kidney Disease (ADPKD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- NODE-1Independent statistical analysis of Efficacy and Safety of Intranasal MSP-2017 (Etripamil) for the Conversion of PSVT to Sinus Rhythm: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- NOH303Independent statistical analysis of Open-Label Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- NOH304Independent statistical analysis of Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH) (Droxi-304): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- NOHARMIndependent statistical analysis of Novel Use Of Hydroxyurea in an African Region With Malaria: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01976416).
- NOLANIndependent statistical analysis of NOLAN: Naproxen or Loratadine and Neulasta: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01712009).
- NOM-ERAIndependent statistical analysis of Non-Operative Management and Early Response Assessment in Rectal Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03904043).
- NOMIIndependent statistical analysis of Nitric Oxide in Myocardial Infarction Size: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00568061).
- Non Interventional Study in Patients With Open Angle Glaucoma and/or Ocular Hypertension Treated With XALATAN®: Complete Statistical AnalysisIndependent statistical analysis of Non Interventional Study in Patients With Open Angle Glaucoma and/or Ocular Hypertension Treated With XALATAN®: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Non Invasive Ventilation as Airway Clearance in Patients With Cystic Fibrosis: Complete Statistical AnalysisIndependent statistical analysis of Non Invasive Ventilation as Airway Clearance in Patients With Cystic Fibrosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Non-comparative Trial of the Combination of HCQ and AZI in the Treatment of ICU Patients: Complete Statistical AnalysisIndependent statistical analysis of Non-comparative Trial of the Combination of HCQ and AZI in the Treatment of ICU Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Non-Contrast 4DCT to Detect Pulmonary Thromboembolic Events: Complete Statistical AnalysisIndependent statistical analysis of Non-Contrast 4DCT to Detect Pulmonary Thromboembolic Events: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03183063).
- Non-dispensing Study to Check Prescription Equivalence of Two Daily Disposable Toric Contact Lens Types: Complete Statistical AnalysisIndependent statistical analysis of Non-dispensing Study to Check Prescription Equivalence of Two Daily Disposable Toric Contact Lens Types: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Non-DrinkerIndependent statistical analysis of Acetaminophen Adduct Formation in Non-Drinkers Taking Therapeutic Doses of Acetaminophen for Ten Consecutive Days: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Non-inferiority Study of XM02 Filgrastim (Granix) and Filgrastim (Neupogen) in Combination With Plerixafor for Autologous Stem Cell Mobilization in Patients With Multiple Myeloma or Non-Hodgkin Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of Non-inferiority Study of XM02 Filgrastim (Granix) and Filgrastim (Neupogen) in Combination With Plerixafor for Autologous Stem Cell Mobilization in Patients With Multiple Myeloma or Non-Hodgkin Lymphoma: primary endpoint…
- Non-interventional Post-authorisation Study to Document the Immunogenicity, Safety, and Efficacy of NUWIQ: Complete Statistical AnalysisIndependent statistical analysis of Non-interventional Post-authorisation Study to Document the Immunogenicity, Safety, and Efficacy of NUWIQ: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Non-Interventional Study Describing Direct Costs Related to Anti-coagulation Treatment: Complete Statistical AnalysisIndependent statistical analysis of Non-Interventional Study Describing Direct Costs Related to Anti-coagulation Treatment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04435769).
- Non-interventional Study of Long-term Treatment of Psoriasis With Calcipotriol Plus Betamethasone in Gel Formulation: Complete Statistical AnalysisIndependent statistical analysis of Non-interventional Study of Long-term Treatment of Psoriasis With Calcipotriol Plus Betamethasone in Gel Formulation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Non-interventional Study of the Effect of Smoking Status of the Patient on the Success of Etanercept Therapy in Psoriasis: Complete Statistical AnalysisIndependent statistical analysis of Non-interventional Study of the Effect of Smoking Status of the Patient on the Success of Etanercept Therapy in Psoriasis: primary endpoint results, effect estimate with confidence interval, sample-size…
- Non-interventional Study, Long Term Treatment on Glabellar Lines With Dysport® in Subjects of Chinese Origin: Complete Statistical AnalysisIndependent statistical analysis of Non-interventional Study, Long Term Treatment on Glabellar Lines With Dysport® in Subjects of Chinese Origin: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Non-invasive Cervical Electrical Stimulation for SCI: Complete Statistical AnalysisIndependent statistical analysis of Non-invasive Cervical Electrical Stimulation for SCI: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03414424).
- Non-Invasive Characterization in Cardiac Sarcoidosis: Complete Statistical AnalysisIndependent statistical analysis of Non-Invasive Characterization in Cardiac Sarcoidosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02017522).
- Non-Invasive Cooling of Fat Cells: Complete Statistical AnalysisIndependent statistical analysis of Non-Invasive Cooling of Fat Cells: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00762437).
- Non-invasive Estimation of CSF Pressure Using MRI in Patients With Spontaneous Intracranial Hypotension: Complete Statistical AnalysisIndependent statistical analysis of Non-invasive Estimation of CSF Pressure Using MRI in Patients With Spontaneous Intracranial Hypotension: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Non-Invasive Hemoglobin Monitoring in Patients With Hemorrhage: Complete Statistical AnalysisIndependent statistical analysis of Non-Invasive Hemoglobin Monitoring in Patients With Hemorrhage: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01709786).
- Non-invasive Intermittent Theta Burst Stimulation of the Dorsolateral Prefrontal Cortex in Functional Movement Disorders: Complete Statistical AnalysisIndependent statistical analysis of Non-invasive Intermittent Theta Burst Stimulation of the Dorsolateral Prefrontal Cortex in Functional Movement Disorders: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Non-invasive Nerve Stimulation and Cognitive Training to Improve Cognitive Performance in Healthy Older Adults: Complete Statistical AnalysisIndependent statistical analysis of Non-invasive Nerve Stimulation and Cognitive Training to Improve Cognitive Performance in Healthy Older Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Non-Invasive Neurostimulation for the Prevention of Chronic Migraine: Complete Statistical AnalysisIndependent statistical analysis of Non-Invasive Neurostimulation for the Prevention of Chronic Migraine: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01667250).
- Non-invasive Tidal Volume Monitoring Using the Linshom Respiratory Monitoring Device: Complete Statistical AnalysisIndependent statistical analysis of Non-invasive Tidal Volume Monitoring Using the Linshom Respiratory Monitoring Device: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03279458).
- Non-invasive Vagus Nerve Stimulation (nVNS) in Pediatric Chronic Inflammatory Demyelinating Polyneuropathy (CIDP): Complete Statistical AnalysisIndependent statistical analysis of Non-invasive Vagus Nerve Stimulation (nVNS) in Pediatric Chronic Inflammatory Demyelinating Polyneuropathy (CIDP): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Non-Invasive Ventilation Via a Helmet Device for Patients Respiratory Failure: Complete Statistical AnalysisIndependent statistical analysis of Non-Invasive Ventilation Via a Helmet Device for Patients Respiratory Failure: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01680783).